NEAM
BMY icon

New England Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

New England Asset Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.43M Hold
40,036
– – 0.31% 73
2025
Q4 		$2.16M Hold
40,036
– – 0.28% 72
2025
Q3 		$1.81M Buy
40,036
+315
+0.8% +$14.7K 0.24% 82
2025
Q2 		$1.84M Buy
39,721
+245
+0.6% +$12K 0.29% 79
2025
Q1 		$2.41M Buy
39,476
+305
+0.8% +$17.8K 0.39% 75
2024
Q4 		$2.22M Sell
39,171
-7,600
-16% -$425K 0.38% 77
2024
Q3 		$2.42M Buy
46,771
+1,330
+3% +$62.4K 0.38% 75
2024
Q2 		$1.89M Sell
45,441
-1,235
-3% -$55.3K 0.31% 74
2024
Q1 		$2.53M Sell
46,676
-530
-1% -$27K 0.39% 70
2023
Q4 		$2.42M Sell
47,206
-32,325
-41% -$1.7M 0.39% 73
2023
Q3 		$4.62M Sell
79,531
-2,000
-2% -$123K 0.76% 49
2023
Q2 		$5.21M Hold
81,531
– – 0.76% 46
2023
Q1 		$5.65M Sell
81,531
-4,865
-6% -$343K 0.84% 43
2022
Q4 		$6.22M Sell
86,396
-100
-0.1% -$7.54K 0.11% 41
2022
Q3 		$6.15M Sell
86,496
-22,675
-21% -$1.64M 0.1% 39
2022
Q2 		$8.41M Buy
109,171
+700
+0.6% +$53.3K 0.14% 27
2022
Q1 		$7.92M Buy
108,471
+1,200
+1% +$80.6K 0.13% 31
2021
Q4 		$6.69M Buy
107,271
+9,800
+10% +$575K 0.1% 34
2021
Q3 		$5.77M Buy
97,471
+29,021
+42% +$1.91M 0.1% 37
2021
Q2 		$4.57M Buy
68,450
+2,450
+4% +$160K 0.08% 43
2021
Q1 		$4.17M Buy
66,000
+1,350
+2% +$84K 0.08% 48
2020
Q4 		$4.01M Buy
64,650
+1,600
+3% +$98.4K 0.08% 45
2020
Q3 		$3.8M Sell
63,050
-2,250
-3% -$135K 0.09% 45
2020
Q2 		$3.84M Sell
65,300
-5,700
-8% -$341K 0.09% 41
2020
Q1 		$3.96M Buy
71,000
+4,300
+6% +$263K 0.09% 39
2019
Q4 		$4.28M Sell
66,700
-1,050
-2% -$60.1K 0.07% 44
2019
Q3 		$3.44M Buy
67,750
+5,050
+8% +$237K 0.06% 54
2019
Q2 		$2.84M Buy
62,700
+9,455
+18% +$440K 0.06% 61
2019
Q1 		$2.54M Buy
53,245
+2,110
+4% +$105K 0.05% 64
2018
Q4 		$2.66M Buy
51,135
+1,950
+4% +$105K 0.06% 58
2018
Q3 		$3.05M Buy
49,185
+185
+0.4% +$11K 0.05% 57
2018
Q2 		$2.71M Buy
49,000
+5,200
+12% +$281K 0.05% 55
2018
Q1 		$2.77M Buy
43,800
+1,600
+4% +$103K 0.05% 52
2017
Q4 		$2.59M Buy
42,200
+200
+0.5% +$12.5K 0.05% 57
2017
Q3 		$2.68M Hold
42,000
– – 0.06% 58
2017
Q2 		$2.34M Sell
42,000
-900
-2% -$49K 0.07% 56
2017
Q1 		$2.33M Buy
42,900
+7,800
+22% +$428K 0.04% 69
2016
Q4 		$2.05M Buy
35,100
+4,000
+13% +$219K 0.06% 70
2016
Q3 		$1.68M Buy
31,100
+400
+1% +$25.7K 0.06% 83
2016
Q2 		$2.26M Buy
30,700
+200
+0.7% +$14.1K 0.08% 64
2016
Q1 		$1.95M Sell
30,500
-6,200
-17% -$391K 0.06% 70
2015
Q4 		$2.52M Buy
36,700
+2,300
+7% +$152K 0.06% 52
2015
Q3 		$2.04M Buy
34,400
+2,800
+9% +$178K 0.05% 82
2015
Q2 		$2.1M Buy
31,600
+800
+3% +$52.7K 0.05% 80
2015
Q1 		$1.99M Sell
30,800
-8,080
-21% -$506K 0.05% 82
2014
Q4 		$2.3M Hold
38,880
– – 0.06% 67
2014
Q3 		$1.99M Sell
38,880
-5,500
-12% -$275K 0.05% 85
2014
Q2 		$2.15M Sell
44,380
-11,791
-21% -$581K 0.05% 94
2014
Q1 		$2.92M Sell
56,171
-1,100
-2% -$58.5K 0.07% 76
2013
Q4 		$3.04M Sell
57,271
-14,300
-20% -$728K 0.08% 76
2013
Q3 		$3.31M Buy
71,571
+19,400
+37% +$852K 0.1% 68
2013
Q2 		$2.33M Buy
+52,171
New +$2.26M 0.07% 74

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

New England Asset Management's BMY Position: Q1 2026 in Review

New England Asset Management held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 40,036 shares worth $2.43M. The position accounts for 0.31% of the portfolio, ranked #73.

New England Asset Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.41M in Q2 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • New England Asset Management held 40,036 shares of Bristol-Myers Squibb worth $2.43M as of Q1 2026.
  • New England Asset Management left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.31% of New England Asset Management's portfolio in Q1 2026, its #73 holding.
  • New England Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • New England Asset Management's Bristol-Myers Squibb position peaked at $8.41M in Q2 2022.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on New England Asset Management's 13F filing for Q1 2026, filed 15 May 2026.